Distribution of Cholesterol within High Density Lipoproteins Fractionated by Immunoaffinity Chromatography

  • Daniel Pometta
  • Richard W. James
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 285)


Cholesterol enjoys notoriety as a pro or anti-atherogenic lipid by virtue of the lipoprotein with which it is associated. This simplistic interpretation is most evident in the positive and negative correlations with the atherosclerotic process manifested by cholesterol associated with the most abundant lipoprotein species, respectively low density (LDL) and high density (HDL) lipoproteins 1,2. The statement requires qualification, however, when lipoprotein sub-populations are contemplated. Thus, within the HDL density spectrum, the protective influence is largely believed to reside within the ultracentrifugally defined lower density HDL-2 subclass 3. HDL-3 enjoys much less support as an anti-atherogenic lipoprotein particle, a somewhat unsatisfactory state of affairs when considering mechanistic explanations of the function of HDL. Notably, particles of the size of HDL-3 are the principal acceptors of cellular cholesterol, the initiating step in reverse cholesterol transport 4. In addition, they can act as a repository for lipids shed from triglyceride-rich lipoproteins, greatly facilitating the catabolic removal of these potentially atherogenic lipoprotein particles 5. Further subfractionation of lipoproteins into, hopefully, metabolically homogenous sub-populations is one approach which should yield more satisfying explanations. This is the rationale behind the studies described in the present report.


High Density Lipoprotein Reverse Cholesterol Transport Lipoprotein Particle Immunoaffinity Chromatography European Atherosclerosis Society 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    NIH Consensus Development Conference, Lowering blood cholesterol to prevent heart disease, JAMA., 253: 2080 (1985)CrossRefGoogle Scholar
  2. Study group, European Atherosclerosis Society, The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society, Europ. HeartJ., 9: 571 (1988)Google Scholar
  3. 3.
    N.E. Miller, Association of high density lipoprotein subclasses with ischaemic heart disease and coronary atherosclerosis, Am. Heart J.. 113: 589 (1987)PubMedCrossRefGoogle Scholar
  4. 4.
    J.F. Oram, Effects of high density lipoprotein subfractions on cholesterol homeostasis in human fibroblasts and arterial smooth muscle cells. Arteriosclerosis, 3: 420 (1983)PubMedCrossRefGoogle Scholar
  5. 5.
    S. Eisenberg, High density lipoprotein metabolism, J. Lipid Res., 25: 1017 (1984)PubMedGoogle Scholar
  6. 6.
    P. Alaupovic, The physicochemical and immunological heterogeneity of human plasma high density lipoproteins, in: ’Clinical and metabolic aspects of high density lipoproteins,’ N.E. Miller and G.J. Miller, eds., Elsevier, Amsterdam (1984)Google Scholar
  7. 7.
    M.C. Cheung and J.J. Albers, Characterisation of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A II, J. Biol. Chem.. 259: 12201 (1984)PubMedGoogle Scholar
  8. R.W. James and D. Pometta, Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations, Atherosclerosis, In PressGoogle Scholar
  9. 9.
    R.W. James, A. Proudfoot and D. Pometta, Immunoaffinity fractionation of high density lipoprotein subclasses 2 and 3 using anti-apolipoprotein A-I and A-II immunosorbent gels, Biochim. Biophys. Acta. 1002: 292 (1989)PubMedGoogle Scholar
  10. R.W. James and D. Pometta, Differences in lipoprotein subfraction composition and distribution between diabetic patients and controls. A study in male, type I (insulin dependent) diabetes, Diabetes. In PressGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Daniel Pometta
    • 1
  • Richard W. James
    • 1
  1. 1.Division de Diabétologie, Département de MédecineHôpital cantonal universitaireGenevaSwitzerland

Personalised recommendations